Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The local immune landscape determines tumor PD-L1 heterogeneity and sensitivity to therapy
Wei Yuan, Qiyi Zhao, Zhiliang Gao, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 8, pp. 3347-3360
Open Access | Times Cited: 104

Showing 26-50 of 104 citing articles:

Research progress of abnormal lactate metabolism and lactate modification in immunotherapy of hepatocellular carcinoma
Yi‐Wei Xu, Xiaodong Hao, Yidan Ren, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 23
Phenotypic Heterogeneity, Bidirectionality, Universal Cues, Plasticity, Mechanics, and the Tumor Microenvironment Drive Cancer Metastasis
Claudia Tanja Mierke
Biomolecules (2024) Vol. 14, Iss. 2, pp. 184-184
Open Access | Times Cited: 11
Beyond the concept of cold and hot tumors for the development of novel predictive biomarkers and the rational design of immunotherapy combination
Éléonore De Guillebon, Antoine Dardenne, Antonin Saldmann, et al.
International Journal of Cancer (2020) Vol. 147, Iss. 6, pp. 1509-1518
Open Access | Times Cited: 57
NF-κB in Cancer Immunity: Friend or Foe?
Guilhem Lalle, Julie Twardowski, Yenkel Grinberg‐Bleyer
Cells (2021) Vol. 10, Iss. 2, pp. 355-355
Open Access | Times Cited: 49
The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapy
Minsu Kwon, Hanul Jung, Gi‐Hoon Nam, et al.
Journal of Controlled Release (2021) Vol. 331, pp. 321-334
Open Access | Times Cited: 46
Blockade of AIM2 inflammasome or α1-AR ameliorates IL-1β release and macrophage-mediated immunosuppression induced by CAR-T treatment
Dan Liu, Xiyue Xu, Yulian Dai, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 1, pp. e001466-e001466
Open Access | Times Cited: 45
Immune checkpoint therapy-elicited sialylation of IgG antibodies impairs antitumorigenic type I interferon responses in hepatocellular carcinoma
Ruiqi Wu, Xiang‐Ming Lao, Dong‐Ping Chen, et al.
Immunity (2022) Vol. 56, Iss. 1, pp. 180-192.e11
Open Access | Times Cited: 35
NF-κB in Cell Deaths, Therapeutic Resistance and Nanotherapy of Tumors: Recent Advances
Xuesong Wu, Liang Sun, Fangying Xu
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 783-783
Open Access | Times Cited: 19
Salvia mitiorrhiza Bunge aqueous extract attenuates infiltration of tumor-associated macrophages and potentiates anti-PD-L1 immunotherapy in colorectal cancer through modulating Cox2/PGE2 cascade
Mengyao Song, Cheng Qian, Teng Zhang, et al.
Journal of Ethnopharmacology (2023) Vol. 316, pp. 116735-116735
Closed Access | Times Cited: 18
High baseline tumor burden‐associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2‐STAT3‐PD‐L1 pathway
Zhaowei Wen, Huiying Sun, Zhihua Zhang, et al.
Cancer Communications (2023) Vol. 43, Iss. 5, pp. 562-581
Open Access | Times Cited: 17
Detailed Characterization of Immune Cell Infiltrate and Expression of Immune Checkpoint Molecules PD-L1/CTLA-4 and MMR Proteins in Testicular Germ Cell Tumors Disclose Novel Disease Biomarkers
João Lobo, Ângelo Rodrigues, Rita de Cássia Avellaneda Guimarães, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1535-1535
Open Access | Times Cited: 52
Infiltration of tumor‐associated macrophages is involved in tumor programmed death‐ligand 1 expression in early lung adenocarcinoma
Toshiyuki Shima, Masayuki Shimoda, Takao Shigenobu, et al.
Cancer Science (2019) Vol. 111, Iss. 2, pp. 727-738
Open Access | Times Cited: 44
Targeting STAT3 and STAT5 in Tumor-Associated Immune Cells to Improve Immunotherapy
Grégory Verdeil, Toby Lawrence, Anne‐Marie Schmitt‐Verhulst, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1832-1832
Open Access | Times Cited: 43
Plasma cells shape the mesenchymal identity of ovarian cancers through transfer of exosome-derived microRNAs
Zhengnan Yang, Wei Wang, Linjie Zhao, et al.
Science Advances (2021) Vol. 7, Iss. 9
Open Access | Times Cited: 41
Immune Landscape of Pituitary Tumors Reveals Association Between Macrophages and Gonadotroph Tumor Invasion
Moitza Principe, Marie Chanal, Mirela Diana Ilie, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 11, pp. 3459-3473
Open Access | Times Cited: 40
Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma
Dong-Jun Park, Pil Soo Sung, Gil-Won Lee, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4710-4710
Open Access | Times Cited: 33
The role of programmed death receptor (PD‐)1/PD‐ligand (L)1 in periodontitis and cancer
Sabine Groeger, Joerg Meyle
Periodontology 2000 (2024) Vol. 96, Iss. 1, pp. 150-169
Open Access | Times Cited: 5
Manganese(III) Phthalocyanine Complex Nanoparticle-Loaded Glucose Oxidase to Enhance Tumor Inhibition through Energy Metabolism and Macrophage Polarization
Zhaoyang Liu, Chao Li, Yushi Cao, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 3, pp. 1862-1877
Closed Access | Times Cited: 5
Polarization of M2 Tumor-associated Macrophages (TAMs) in Cancer Immunotherapy
Indy Bui, Benjamin Bonavida
Critical Reviews™ in Oncogenesis (2024) Vol. 29, Iss. 4, pp. 75-95
Closed Access | Times Cited: 5
Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer?
Sanjay Popat, Christian Grohé, J. Corral, et al.
Lung Cancer (2020) Vol. 144, pp. 76-84
Open Access | Times Cited: 36
MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma
Zhuochao Liu, Junxiang Wen, Chuanlong Wu, et al.
Aging (2020) Vol. 12, Iss. 2, pp. 1213-1236
Open Access | Times Cited: 33
B cell heterogeneity, plasticity, and functional diversity in cancer microenvironments
Wei Yuan, Chun-Xiang Huang, Christos Xiao, et al.
Oncogene (2021) Vol. 40, Iss. 29, pp. 4737-4745
Closed Access | Times Cited: 30
Antitumor effect of CAR-T cells targeting transmembrane tumor necrosis factor alpha combined with PD-1 mAb on breast cancers
Hongping Ba, Zigang Dai, Zunyue Zhang, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 1, pp. e003837-e003837
Open Access | Times Cited: 11
Forces at play: exploring factors affecting the cancer metastasis
Farooq Riaz, Jing Zhang, Fan Pan
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Association of metabolomics with PD-1 inhibitor plus chemotherapy outcomes in patients with advanced non-small-cell lung cancer
Liang Zheng, Fang Hu, Lin Huang, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 4, pp. e008190-e008190
Open Access | Times Cited: 4

Scroll to top